Foot and ankle orthopedic medical device company Paragon 28 reported $42.5 million in revenue in the second quarter, up 19 percent from the same period last year.
Five fast facts worth noting:
1. Revenue growth: U.S. revenue grew 19 percent to $36.8 million, while international revenue reached $5.7 million.
2. Gross margin: Paragon 28 saw an 82 percent gross margin, up from 81.3 percent last year.
3. Operating expenses: Paragon 28's operating expenses reached $43.9 million, up from $43 million last quarter.
4. Losses: Paragon 28 had a net loss of $9.6 million.
5. Future growth: Paragon 28 aims to reach a net revenue of $42.5 million in quarter three and $49.6 million in quarter four.